Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01621568
Title Sunitinib for Advanced Thymus Cancer Following Earlier Treatment
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

thymic carcinoma

thymoma

Therapies

Sunitinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.